Ignite Creation Date:
2024-05-06 @ 1:36 PM
Last Modification Date:
2024-10-26 @ 1:17 PM
Study NCT ID:
NCT04071327
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2019-04-04
Brief Title:
Pulmonary Hypertension Association Registry
Sponsor:
Pulmonary Hypertension Association Inc
Organization:
Pulmonary Hypertension Association Inc
Study Overview
Official Title:
Pulmonary Hypertension Association Registry
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PHAR
Brief Summary:
The PHA Registry PHAR is a national study about people who have pulmonary arterial hypertension PAH and chronic thromboembolic pulmonary hypertension CTEPH PHAR collects information from people with PAH and CTEPH who are cared for in participating PHA-accredited Pulmonary Hypertension Care Centers throughout the US
PHAR will determine how people with PAH and CTEPH are evaluated tested and treated and will observe how well these participants do The goal is to see if people with PH are treated according to recommended guidelines and to see if there are certain factors that can lead to better or worse outcomes
PHAR will include information about people with PAH and CTEPH in the US who are seen at participating PHA-accredited PH Care Centers PHAR contains data about patient care and outcomes Specifically data in the PHAR includes information on diagnosis clinical status socioeconomic status diagnosis test results body size treatment information interest in participating in clinical trials family health and social history and information about smoking alcohol or drug use Participants are followed over time and provide updates such as changes in therapy how often participants need to go to the hospital and survival Such information may help healthcare providers provide better care
PHAR will determine how people with PAH and CTEPH are evaluated tested and treated and will observe how well these participants do The goal is to see if people with PH are treated according to recommended guidelines and to see if there are certain factors that can lead to better or worse outcomes
PHAR will include information about people with PAH and CTEPH in the US who are seen at participating PHA-accredited PH Care Centers PHAR contains data about patient care and outcomes Specifically data in the PHAR includes information on diagnosis clinical status socioeconomic status diagnosis test results body size treatment information interest in participating in clinical trials family health and social history and information about smoking alcohol or drug use Participants are followed over time and provide updates such as changes in therapy how often participants need to go to the hospital and survival Such information may help healthcare providers provide better care
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None